Dr Ainsley M Robinson
Honorary (Fellow)
Department of Medicine
32 Scholarly works
0 Projects
HIGHLIGHTS
2025
Journal article
Dysregulation of cellular metabolism within the gut-brain axis is associated with behavioural changes in chronic intestinal inflammation
DOI: 10.1186/s12974-025-03536-x2025
Presentation
APE1/REF-1 REDOX ACTIVITY INHIBITOR AS A NOVEL ORAL TREATMENT FOR INFLAMMATORY BOWEL DISEASE
2025
Journal article
Sa1801: APE1/REF-1 REDOX ACTIVITY INHIBITOR AS A NOVEL ORAL TREATMENT FOR INFLAMMATORY BOWEL DISEASE
DOI: 10.1016/s0016-5085(25)02169-92024
Journal article
Bone marrow-derived mesenchymal stem cells mitigate chronic colitis and enteric neuropathy via anti-inflammatory and anti-oxidative mechanisms
DOI: 10.1038/s41598-024-57070-62024
Journal article
Tu1728 REF-1 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: EFFICACY, MECHANISMS OF ACTION, AND CLINICAL APPLICATIONS
DOI: 10.1016/s0016-5085(24)03665-52024
Journal article
Krill Oil and Its Bioactive Components as a Potential Therapy for Inflammatory Bowel Disease: Insights from In Vivo and In Vitro Studies
DOI: 10.3390/biom140404472024
Journal article
Alterations in tryptophan metabolism and de novo NAD biosynthesis within the microbiota-gut-brain axis in chronic intestinal inflammation
DOI: 10.3389/fmed.2024.1379335
RECENT SCHOLARLY WORKS
2023
Journal article
APE1/Ref-1 as a Therapeutic Target for Inflammatory Bowel Disease
DOI: 10.3390/biom131115692023
Journal article
Virtual Dementia-Friendly Communities (Verily Connect) Stepped-Wedge Cluster-Randomised Controlled Trial: Improving Dementia Caregiver Wellbeing in Rural Australia
DOI: 10.3390/geriatrics80500852023
Journal article
Sa1755 APE1/REF-1 AS A NOVEL MOLECULAR TARGET FOR IBD TREATMENT
DOI: 10.1016/s0016-5085(23)01969-8